ChemPartner Assists the Mount Sinai Health System in Producing Reagent for COVID-19 Research
Shanghai, China (May 12, 2020) – Shanghai ChemPartner announced they have entered into a non-exclusive agreement with the Mount Sinai Health System (Mount Sinai) to assist in a trial production run of a component of the Mount Sinai COVID-19 serological assay that recently received Emergency Use Auth...ChemPartner and the Gladstone Institutes Announce COVID-19 Research Collaboration
SAN FRANCISCO, Calif. and SHANGHAI, China. (April 15, 2020) – In a new collaboration, Chempartner Corporation (ChemPartner), the US arm of a leading pre-clinical contract research and development organization (CRO), is partnering with scientists at Gladstone Institutes, an independent biomedical res...ChemPartner Introduces New State-of-the-Art Global Operation Center in Shanghai
Shanghai, China (March 17, 2020) – Shanghai ChemPartner announced the opening of a new, state-of-the-art, 24,000 m2 laboratory facility in the Zhangjiang Hi-Tech Park in Shanghai, China. The building, operating as ChemPartner’s new Global Operation Center, houses approximately 700 employees and new ...Dr. Jie Jack Li joins Shanghai ChemPartner as a Vice President of Discovery Chemistry
Shanghai, China (December 17, 2019) – Shanghai ChemPartner announced the appointment of Jie Jack Li, Ph.D. as a Vice President of Discovery Chemistry at the Company headquarters in Shanghai, China. Dr. Li is an established chemist with over 20 years of experience in both medicinal chemistry and proc...
Shanghai ChemPartner was awarded “TOP 10 CMOs in 2019”
Contract manufacturers play a significant role when it comes to manufacturing medical products. By partnering with the right CM, a medical device manufacturer can save plenty of time and overhead costs. Life sciences companies need CMOs due to the potential rise in the number of products that are go...Dr. Teddy Yang appointed to Vice President and Head of Biologics Discovery at Shanghai ChemPartner
Shanghai, China(Mar 28, 2019) – Shanghai ChemPartner today announced the appointment of Teddy Yang, Ph.D. as the Vice President and Head of Biologics Discovery at the company headquarters in Shanghai, China. Dr. Yang has more than 20 years of experience in the pharmaceutical industry. He has previou...ChemPartner Will Participate in BIO-Europe Spring in Vienna, Austria in March 2019
Shanghai, China (March X, 2019) – March 25-27, 2019, ChemPartner will attend the 13th Annual International Partnering Conference BIO-Europe Spring in Vienna, Austria. With nearly 1,500 companies from 55 countries around the world, BIO-Europe is set to be a premier venue to engage with global life sc...
ChemPartner will be at the Boulder Peptide Symposium 2018
ChemPartner, a leader in Peptide Synthesis and Development, will be at the Boulder Peptide Symposium, Sept. 24-27, 2018 in Boulder, Colorado. The program was organized by Dr. Yvonne Angell, who is the Head of Peptide Operations at ChemPartner. There are 43 speakers, including a Showcase of emerging ...